CCAT2 and hepatocellular carcinoma: While rapamycin, the autophagy activator, could reincrease the migratory and invasive abilities of HepG2 and HCCLM3 cells inhibited by CCAT2 knockdown (Figure 1D,E), the results indicated that autophagy might involve in HCC progression.